Are you looking to achieve your weight loss goals while contributing to cutting-edge research? This trial tests a new GLP-1/GIP medication, similar to drugs like Ozempic and Zepbound, for its weight loss benefits.
Qualified Participants Must Be:
- 18 years of age or older
- Overweight or obese (BMI ≥27)
Participants Will Receive:
- Study-related care at no cost
- Compensation for time and travel
Medical insurance is not required for study participation. To learn more about the study or if you’re interested in enrolling, please contact Sophie Maraghi at 202-293-1000 or smaraghi@intimmedicine.com